Home Past Editions Milan 2026
2nd Annual · 2026

MaxPotent Pharma Summit Milan 2026

6–7 May 2026 · Ramada Plaza by Wyndham, Milan, Italy. The second annual edition brought regulators, pharma innovators and CDMOs to Milan for two days on containment performance, HBELs and data integrity, ISPE containment guidance, nitrosamine risk assessment and in-vivo CAR-T manufacturing.

📍
Venue
Ramada Plaza by Wyndham
Milan, Italy · 6–7 May 2026

Download the 2026 Post Event Report

Key Sessions from the Inaugural Summit

Toxicology Aspects in Worker and Patient Safety

Martin Kohan

Managing Toxicologist, SafeBridge Europe, UK

High Containment HPAPI Kilo Lab & Production Development Scale Plant

David Cragin

Senior Director, Occ & Env Health Sciences, EHS and Sustainability, Teva Pharmaceuticals

Cleaning Validation for HPAPI: One Driver to Prevent Cross-Contamination

Andreas Schreiner

Global Validation Leader, Novartis

Advanced HPAPI Containment Systems: Engineered to Handle CPTs Down to 1 ng

Stefano Butti

Technical Sales Director, FPS Pharma

Understanding European Regulatory Requirements for High-Containment Facilities

Giorgio Mari

Senior Process Engineer, Exyte

High Containment HPAPI Kilo Lab & Production Development Scale Plant

Andrew Lemaire

Technical Director of Containment & Micronization Technologies, DEC Group

From Compliance to Competitive Advantage: Embedding Sustainability Across the Pharma Value Chain

Matteo Alaria

Senior Sustainability Leader, former Head of Sustainability, Sartorius

Pre-Reconstruction Risk Evaluation for a Development API Plant: A Cross-Contamination and Containment Assessment

Dr. Ildikó Ziegler

Director of Quality, Hunazine Biotech S.L.

What the First Edition Established

Regulatory Compliance

Updates and insights into navigating HPAPI-specific regulations and global standards.

Containment Technologies

Latest innovations to ensure safe handling of high-potency compounds.

Process Optimisation

Best practices for efficient, scalable and risk-controlled manufacturing.

Risk Mitigation & Safety

Strategies for minimising exposure, ensuring worker safety and maintaining environmental compliance.

Networking & Collaboration

Opportunities to build partnerships and foster knowledge exchange among pharma innovators, CMOs/CDMOs and regulatory experts.

Market Insights

Understanding trends in HPAPI demand, technology adoption and growth projections.

Thought Leadership

Keynote sessions and panel discussions featuring industry leaders and subject-matter experts.

CDMO Insights

Strategies for CMOs/CDMOs to enhance operational efficiency, expand service offerings and collaborate with pharma innovators.

Companies in the Room

AbbVie Accord Healthcare Adare Pharma Solutions Affygility Solutions APC AstraZeneca Bayer be circular Boehringer Ingelheim Bristol Myers Squibb Chiesi COMBER Process Technology Corden Treviglio Eli Lilly Exyte Ferrero Flamma S.p.A. Genmab GENTEC Pharmaceutical Group Gilead GlaxoSmithKline GMP Check GSK HECHT Technologie GmbH Howorth Air Technology HPAPI Project Services Hunazine Biotech Hyntelo Inke Jacobs Italia Johnson & Johnson Kikusui Europe Landoor Lundbeck Menarini Merck Group Nanozen Industries Novartis Novo Nordisk Octapharma OH Consult Pfizer Pharmanoid Rattinox Srl Ravizza & C Srl Recordati Roche SafeBridge Europe Sanofi Sartorius Swati Spentose Takeda TEVA – TAPI Teva Pharmaceuticals TheaPharma Thermo Fisher Scientific ToxHub Srl TransPerfect UCB Pharma Veolia Water Technologies Vis Viva s.r.l. Zoetis

Who Backed Milan 2026

The organisations that sponsored, exhibited and partnered on the 2nd Annual edition.

Telstar
CSV Containment
Lugaia
BSP Pharmaceuticals
CTS Europe
De Dietrich
GfM Milling
Hosokawa Alpine
SKAN
Icrom
Procos
Cerbios
Almac
Selvita
Rottendorf Pharma
Polpharma
Arcadis
Olon
Aragen
Pharma Focus Europe
European Pharmaceutical Manufacturer

Trusted by Industry Leaders

Sponsors, speakers and delegates on the Milan 2026 floor.
The event was exceptionally well organised, offering ample networking opportunities with a large number of attendees and presenters. The hospitality was excellent, and it was a pleasure to interact with colleagues while highlighting the importance of toxicology in areas such as containment, risk assessment, and both worker and patient protection. We look forward to collaborating with Convolign on future events as well.
Martin Kohan
Managing Toxicologist, SafeBridge Europe, UK
We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. The event brought together many customers, key manufacturers, and leading engineering companies, making it a great platform to exchange knowledge, information, and experience. We will definitely look forward to joining next year’s edition.
Stefano Butti
Technical Sales Director, FPS Pharma & Food Systems Srl
Congratulations to the entire team of Convolign Business Consulting for organising such a wonderful event. It was a perfect platform to gain insights into the key factors and technologies shaping high potent drug manufacturing. We also had excellent opportunities to network with peers and connect with new clients.
Andrea Confetti
Chairman, Dipharma Francis Srl
The event was highly informative, and we made some excellent industry contacts to introduce our systems to. The footfall was impressive, and the presentations were insightful. Overall, it was a great event for us, and we look forward to attending the next edition.
Mike Shemeld
Technical Sales Manager, CTS Europe
We had an excellent delegate turnout. The one-to-one meetings were very well organised and provided a great platform to connect with leaders from across various segments of HPAPI drug development. Truly a valuable opportunity for meaningful discussions and collaborations.
Roberto Furlan
Sales Manager, CSV Containment
I found the event very engaging, with a wide range of interesting topics covered. The venue was excellent, offering plenty of opportunities for networking, and the hospitality was truly remarkable.
Andrea Weiss
International Business Strategist, AM Instruments

The Story Continues in Rome